Showing 111 - 120 of 509
Persistent link: https://www.econbiz.de/10011615563
Persistent link: https://www.econbiz.de/10011742885
Persistent link: https://www.econbiz.de/10011647582
Persistent link: https://www.econbiz.de/10010354880
Persistent link: https://www.econbiz.de/10010383164
Persistent link: https://www.econbiz.de/10010188219
Persistent link: https://www.econbiz.de/10011292341
Persistent link: https://www.econbiz.de/10012086434
Persistent link: https://www.econbiz.de/10012810649
Background Relapsed or refractory classic Hodgkin lymphoma (RRcHL) associates with poor prognosis and heavy disease burden to patients. This study evaluated the cost-effectiveness of brentuximab vedotin (BV) in comparison to conventional chemotherapy in patients with RRcHL, from a Chinese...
Persistent link: https://www.econbiz.de/10015358259